Private Equity in Ophthalmology and Optometry
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 127 (4) , 445-455
Abstract
No abstract availableKeywords
Funding Information
- Allergan
- Regeneron
- Allergan
- Roche
- Santen
This publication has 19 references indexed in Scilit:
- An Analysis of Medicare Reimbursement to Ophthalmologists: Years 2012 to 2013American Journal of Ophthalmology, 2017
- The Medicare Access And CHIP Reauthorization Act And The Corporate Transformation Of American MedicineHealth Affairs, 2017
- Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage PatientsOphthalmology, 2017
- Marketplace Plans With Narrow Physician Networks Feature Lower Monthly Premiums Than Plans With Larger NetworksHealth Affairs, 2016
- Less Physician Practice Competition Is Associated With Higher Prices Paid For Common ProceduresHealth Affairs, 2015
- Concentration In Orthopedic Markets Was Associated With A 7 Percent Increase In Physician Fees For Total Knee ReplacementsHealth Affairs, 2015
- Hospitals, Market Share, and ConsolidationJAMA, 2013
- Nurse Staffing and Deficiencies in the Largest For‐Profit Nursing Home Chains and Chains Owned by Private Equity CompaniesHealth Services Research, 2011
- Higher Health Care Quality And Bigger Savings Found At Large Multispecialty Medical GroupsHealth Affairs, 2010
- Physician Practice Size And Variations In Treatments And Outcomes: Evidence From Medicare Patients With AMIHealth Affairs, 2007